Shortwave Diathermy and Pilates Exercises in Patients With Chronic Non-specific Low Back

Sponsor
University of Sao Paulo General Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04048902
Collaborator
(none)
36
1
2
30.9
1.2

Study Details

Study Description

Brief Summary

The aim of this study is to verify the effectiveness of the association of Shortwave Diathermy and Pilates exercises in patients with chronic non-specific low back pain, on the reduction of pain, functional disability and improvement of the quality of life.

Condition or Disease Intervention/Treatment Phase
  • Device: Pilates and Shortwave placebo
  • Device: Pilates and Shortwave active
N/A

Detailed Description

The drawing of the study will be a prospective, randomized controlled trial and double-blind with quantitative approach. Study participants 36 subjects diagnosed with non-specific chronic low back pain, which will be divided in two groups with 18 subjects in each: experimental group, which will be submitted to placebo + exercise shortwave diathermy and the control group to do active + exercise shortwave diathermy. There will be 12 one-hour sessions twice a week. The subjects will apply Shortwave Diathermy for 20 minutes, followed by Pilates mat.

Study Design

Study Type:
Interventional
Actual Enrollment :
36 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effects of Shortwave Diathermy and Pilates Exercises in Patients With Chronic Non-specific Low Back Pain: a Protocol of a Randomized Controlled Trial
Actual Study Start Date :
Mar 6, 2018
Actual Primary Completion Date :
Sep 30, 2020
Actual Study Completion Date :
Sep 30, 2020

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Pilates and Shortwave placebo

In this group the patients will receive 20 minutes of short wave placebo application. The equipment will keep the timer on and the intensity will remain at zero. The patient will be informed that the dose is subsensory and therefore there will be no perception of the passage of the short waves through the body.The application will be performed with two coplanar plates in parallel, arranged on the right and left side of the lumbar region, maintaining a distance of 5 to 10 cm between them, with the patient lying in the dorsal decubitus position

Device: Pilates and Shortwave placebo
Pilates exercises and application of the device without produce thermal effects

Active Comparator: Pilates and Shortwave active

In this group the patients will receive 20 minutes of application of the Shortwave Active continuous mode (thermal effect), with vigorous local thermal sensation.The application will be performed with two coplanar plates in parallel, arranged on the right and left side of the lumbar region, maintaining a distance of 5 to 10 cm between them, with the patient lying in the dorsal decubitus position

Device: Pilates and Shortwave active
Pilates exercises and application of the device producing thermal effects

Outcome Measures

Primary Outcome Measures

  1. Change in pain through Pain visual analogue scale [Before the treatment, up to 3, 6 and 18 weeks]

    Scale with 11 centimeters is used for evaluate pain intensity, being "0" no pain and "10" the worst possible pain

  2. Change in pain through The McGill pain questionnaire [Before the treatment, up to 3, 6 and 18 weeks]

    It is organized in four categories: sensory, affective, evaluative and mixed, with 20 subcategories and 78 words descriptors of pain, describing the quality of pain. The pain evaluation index is the sum of the values added, and each word chosen in each dimension is the maximum score of each category: Sensory = 34, Affective = 17, Evaluative = 5, Mixed = 11, Total = 67.

Secondary Outcome Measures

  1. Functional disability [Before the treatment, up to 3, 6 and 18 weeks]

    The Rolland and Morris Questionnaire, validated in Brazil, will quantify the functional limitations caused by low back pain. The questionnaire is composed of 24 questions related to normal activities of daily living, in which each affirmative answer corresponds to a point. The final score is determined by the sum of the values obtained. Values close to zero represent the best results (lower limitation), and values close to 24 the worst results. Values above 14 points are considered as a severe spinal impairment.

  2. Patients' perceptions of their health-related quality of life: The Short-Form Health Survey questionnaire (SF-36) [Before the treatment, up to 3, 6 and 18 weeks]

    The Short-Form Health Survey questionnaire (SF-36) will assess the health-related quality of life of patients. This instrument contains 36 questions grouped into eight areas: functional capacity (10 items), physical aspects (2 items), pain (2 items), general state of health (5 items), vitality (4 items), social aspects (2 items), emotional (3 items) and mental health (5 items). The values in each domain vary from 0 to 100 and, more indicate a better quality of life.

  3. Perception of global effect [Before the treatment, up to 3, 6 and 18 weeks]

    Evaluates the level of perception of patient recovery through a Scale Numbers of 11 points comparing the onset of symptoms at the beginning of treatment in relation to the last days. It varies from -5 to +5, being -5: extremely worse; zero: no modification; and +5: fully recovered, with the highest score representing greater recovery.

  4. Emotional Functioning [Before the treatment, up to 3, 6 and 18 weeks]

    It will be evaluated by the Brazilian version of the Visual Analog Scale for anxiety. Analogic visual scale for anxiety is a horizontal line of 100 mm in length. The tip left without anxiety and the right tip means worse anxiety.

  5. Depressive Symptom [Before the treatment, up to 3, 6 and 18 weeks]

    It will be evaluated by the Brazilian version of the Beck Depression Inventory, a self-assessment measure of depression. It is a questionnaire with 21 items whose intensity ranges from 0 to 3 points. Largest scores indicate more depressive symptoms.

  6. Symptoms and adverse events [Before the treatment, up to 3, 6 and 18 weeks]

    The record of the symptoms and adverse events that occurred during the established behavior will be captured passively through spontaneous reports of the patient. The active catch will use a questionnaire with a record of the duration and intensity of the adverse symptom reported by the patient. You will then be asked to the patient graduates the certainty of their affirmations according to a Likert scale (being 1 not certain and 5 total certainty).

  7. Patient Satisfaction: The MedRisk scale [Patients will be evaluated up to 6 weeks]

    The MedRisk scale consists of 20 items, 10 items related to the therapist-patient interaction; 8 items involving evaluation of the infrastructure and work organization of the physical therapy clinic and 2 items that are considered as global evaluation of the treatment. The patient elects level of satisfaction in each item by selecting a Likert scale ranging from 1 "completely disagree" to 5 "agree completely" or through an option "not applicable", with high scores representing high satisfaction.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • individuals diagnosed with chronic non-specific low back pain for a period of more than 3 months, without irradiation for lower limbs;

  • who present pain intensity greater than 3 points in the Numerical Pain Scale;

  • to sign the Free and Informed Consent Form.

Exclusion Criteria:
  • BMI> 30;

  • previous surgeries in the spine;

  • severe spinal affection (tumors, infection, unconsolidated or vicious consolidation fractures, inflammatory diseases);

  • rheumatic disease;

  • contraindication to performing the exercises according to the American College of Sports Medicine Guidelines;

  • degenerative or inflammatory joint and other body segments;

  • patients who are in labor litigation;

  • pregnancy;

  • patients who are undergoing other type of physiotherapeutic or drug treatment.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Physical Therapy, Speech and Occupational Therapy of University of São Paulo São Paulo Brazil 05360-160

Sponsors and Collaborators

  • University of Sao Paulo General Hospital

Investigators

  • Principal Investigator: Raquel A Casarotto, PhD, University of Sao Paulo
  • Principal Investigator: Sandra Amaral, Bachelor, University of Sao Paulo

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Raquel A. Casarotto, Principal Investigator, University of Sao Paulo General Hospital
ClinicalTrials.gov Identifier:
NCT04048902
Other Study ID Numbers:
  • 48391615.9.0000.0065
First Posted:
Aug 7, 2019
Last Update Posted:
Oct 5, 2020
Last Verified:
Oct 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Raquel A. Casarotto, Principal Investigator, University of Sao Paulo General Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 5, 2020